| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Wilson Robert N serves as a Director at CALC and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 7 buys and 0 sells. Those positions are worth an estimated $9.4M at current prices.
Historically, Wilson Robert N's trades have earned a below-average insider score of 37/100 across 6 rated trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -43.1%.
The biggest single holding is SCHW (~$8.1M) as Director.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 18, 2025 | CALC Calcimedica, Inc. | Director | Buy | 4,500 | $2.87 | $12,915.00 | +1.1% | +8.0% | -75.5% | |
| Nov 1, 2024 | CALC Calcimedica, Inc. | Director | Buy | 53,333 | $3.75 | $199,998.75 | +14.6% | -27.6% | -15.7% | |
| Aug 23, 2024 | CALC Calcimedica, Inc. | Director | Buy | 54,000 | $3.72 | $200,826.00 | +17.4% | -14.0% | -30.7% | |
| Jun 28, 2024 | CALC Calcimedica, Inc. | Director | Buy | 51,278 | $3.52 | $180,498.56 | +19.8% | +14.1% | -63.9% | |
| Jun 27, 2024 | CALC Calcimedica, Inc. | Director | Buy | 8,443 | $3.23 | $27,304.66 | +3.4% | +37.8% | -54.6% | |
| Dec 11, 2023 | CALC Calcimedica, Inc. | Director | Buy | 506 | $3.30 | $1,669.80 | +0.3% | +32.2% | -17.9% | |
| Apr 6, 2015 | MDGL Madrigal Pharmaceuticals, Inc. | Director | Buy | 50,000 | $1.75 | $87,500.00 | +7.1% | - | - |